Literature DB >> 28992887

Risk factors and managements of hemorrhage associated with pancreatic fistula after pancreaticoduodenectomy.

Xing Liang1, Li-Gang Shi1, Jun Hao2, An-An Liu1, Dan-Lei Chen1, Xian-Gui Hu2, Cheng-Hao Shao3.   

Abstract

BACKGROUND: Post-pancreaticoduodenectomy pancreatic fistula associated hemorrhage (PPFH) is one of the leading lethal complications. Our study was to analyze the risk factors and managements of hemorrhage associated with pancreatic fistula after pancreaticoduodenectomy, and to evaluate treatment options.
METHOD: We analyzed 445 patients who underwent pancreaticoduodenectomy or pylorus-preserving pancreaticoduodenectomy and evaluated the relevance between clinical data and PPFH.
RESULTS: The incidence of postoperative pancreatic fistula (POPF) was 27.42% (122/445), and the incidence of PPFH was 4.49% (20/445). Among the 20 patients with PPFH, 7 died and 13 were cured. Interventional angiographic therapy was performed for 10 patients and 5 were successfully treated. Relaparotomy was performed for 5 patients and 2 were successfully cured. Univariate logistic regression analysis indicated that several risk factors were related to PPFH: the nature of tumor (carcinoid/low-grade or high-grade malignancy), preoperative day 1 serum prealbumin, preoperative day 1 total bilirubin (TBIL), operative time, blood loss in the operation, operative method (vascular resection and revascularization), postoperative day 3 TBIL, biliary fistula, and the grade of POPF. The multivariate stepwise logistic regression analysis demonstrated that the nature of tumor and the grade of POPF were independently risk factors of PPFH. Receiver operating characteristic curve indicated that preoperative day 1 serum prealbumin level <173 mg/L and postoperative day 3 TBIL level ≥168 µmol/L were the risk factors of PPFH.
CONCLUSIONS: The risk of PPFH was found to be increased with high potential malignancy and high grade of POPF. Angiography-embolization is one of the major and effective therapies for PPFH. Extraluminal-intraluminal PPFH is more serious and needs more aggressive treatments.
Copyright © 2017 The Editorial Board of Hepatobiliary & Pancreatic Diseases International. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  hemorrhage; pancreatic neoplasms; pancreaticoduodenectomy; postoperative pancreatic fistula; risk factors

Mesh:

Substances:

Year:  2017        PMID: 28992887     DOI: 10.1016/S1499-3872(17)60061-4

Source DB:  PubMed          Journal:  Hepatobiliary Pancreat Dis Int


  4 in total

1.  Endovascular therapy choices for different sites of delayed postoperative arterial hemorrhage after hepatobiliary pancreatic surgery: a retrospective study.

Authors:  Xiaohe Yu; Xue Liu; Jian Huang; Shuqun Shen; Naijian Ge; Yefa Yang; Hua Wang
Journal:  Gland Surg       Date:  2021-09

2.  Pancreatoduodenectomy without Vascular Resection in Patients with Primary Resectable Adenocarcinoma and Unilateral Venous Contact: A Matched Case Study.

Authors:  Luca Morelli; Raffaella Berchiolli; Simone Guadagni; Matteo Palmeri; Niccolò Furbetta; Desirée Gianardi; Matteo Bianchini; Niccola Funel; Giovanni Caprili; Luca Emanuele Pollina; Giulio Di Candio; Franco Mosca; Gregorio Di Franco; Alfred Cuschieri
Journal:  Gastroenterol Res Pract       Date:  2018-11-25       Impact factor: 2.260

3.  Preoperative Computed Tomography Imaging of the Pancreas Identifying Predictive Factors for the Progression of Grade A, or Biochemical Leak, to Grade B Postoperative Pancreatic Fistula Following Pancreaticoduodenectomy: A Retrospective Study.

Authors:  Feng-Hao Liu; Xiao-Zhong Jiang; Bin Huang; Yu Yu
Journal:  Med Sci Monit       Date:  2021-02-25

4.  A newly improved POSSUM scoring system for prediction of morbidity in patients with pancreaticoduodenectomy.

Authors:  Zhi-Lei Zhang; Lian Chen; Li Peng; Sheng-Chao Li; Peng Guo; Meng Zhang
Journal:  Transl Cancer Res       Date:  2020-09       Impact factor: 1.241

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.